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Accepted 1 August 2012AbstractObjective: To evaluate the impact of the duration of cryopreservation of testicular sperm on clinical and neonatal outcomes after intra-
cytoplasmic sperm injection (ICSI) for patients experiencing azoospermia.
Materials and methods: This study included 132 azoospermic men who participated in 212 ICSI cycles. The participating men underwent
testicular biopsy for the cryopreservation of tissue to be used for subsequent ICSI cycles. The duration of the storage of testicular sperm was
determined by the time of oocyte retrieval. Fertilization, embryo development in vitro, pregnancy rates, and neonatal outcomes were assessed.
Results: Although the mean percentage of viability decreased from 73.2% prior to freezing to 50.2% after thawing, viable spermatozoa were
visualized subsequent to thawing of the tissue samples for all patients. The potential for fertilization and subsequent embryonic development was
not influenced by the duration of sperm cryopreservation up to 2 years longer. The pregnancy outcomes also varied independently of the duration
of sperm cryopreservation. The duration of storage did not appear to affect the neonatal outcomes adversely, including the Apgar score and
intensive care unit admission rates, although neonatal outcomes were influenced by advanced maternal age. It also has no obvious impact on the
major and minor congenital malformation rate of the newborns.
Conclusion: ICSI outcomes, pregnancy outcome, neonatal outcome, and congenital malformation rate appear not to be affected by the duration
of the period of cryostorage. An earlier start of the ICSI cycle following the testicular sperm cryopreservation is preferable because longer
preservation is associated with more advanced maternal age.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Intracytoplasmic sperm injection (ICSI) was developed
about 20 years ago, and is used worldwide as a standard
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http://dx.doi.org/10.1016/j.tjog.2012.08.003retrieval offers a treatment for patients with obstructive or
nonobstructive azoospermia, and testicular sperm extraction
(TESE) has become one of the most popular options [2]. The
technique of cryopreservation of testicular sperm was devel-
oped subsequently, and has generated interest because of
several advantages. First, it may avoid a repeat testicular bi-
opsy. Second, obtaining TESE prior to ICSI could ensure the
availability of sperm on the day of the in vitro fertilization
procedure. Furthermore, the couple would not require simul-
taneous procedures, and would thus avoid possible subsequentcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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freezing of testicular spermatozoa has been performed for
couples with azoospermia in our hospital [5], and elsewhere
[6e8]. Some studies have revealed similar results in the rate of
pregnancy achieved by fresh and frozenethawed testicular
sperm. It would appear that cryopreserved sperm is not infe-
rior to fresh sperm [4,8]. In addition, a multicenter study
compared the prenatal outcome, congenital anomalies, and
neuro-developmental features of children conceived with ICSI
with these outcomes in those conceived naturally [1]. In our
previous study, the assisted reproductive technology outcome
appears not to have been affected by the duration of period of
cryostorage [3]. The aim of the present investigation was to
further analyze pregnancy outcome, and neonatal data from
children conceived through this technique.
Material and methodsStudy populationThis study was completed during a 13-year period
commencing in 1997. Each participant underwent a physical
examination of his genitalia by an experienced urologist in
order to evaluate the anatomy of the seminal vesicles, prostate,
distal vasa deferentia, and ejaculatory ducts. Since 1997, there
have been 188 couples of whom the male partner suffered
from azoospermia and underwent TESE for routine cryo-
preservation at our hospital. Thawed testicular spermatozoa
were used subsequently for an ICSI cycle for 212 of these 132
couples from 1997 until the present time. Women included in
this study had also received routine infertility work-up.Testicular tissue extraction and the preparation of
testicular spermThe TESE procedure basically follows that described in a
previous report [5]. Briefly, a piece of testicular tissue was
squeezed out under local anesthesia. The specimen(s) were
transported to our infertility laboratory for analysis, process-
ing, and cryopreservation. The specimen was placed in a petri
dish with 2 mL of human tubal fluid medium where it was
minced and dispersed mechanically. Using microscopy, we
observed and quantified the spermatozoa in a 10 mL aliquot of
specimens obtained in this manner. If spermatozoa were found
to be present, the total number of spermatozoa/mL was esti-
mated (by multiplying by 200).Cryopreservation of testicular spermatozoaThe method adopted for the cryopreservation of testicular
spermatozoa has been published previously [3,5].Assessment of vitality of testicular spermatozoaAfter resuspension of the pellets in the preparation of
testicular tissues, six fractions from six patients were allocated
for assessment of vitality of the fresh spermatozoa, which wasevaluated with the eosin Y staining method and the hypo-
osmotic swelling test. For assessment of vitality of the post-
thawed spermatozoa thirteen patients agreed, after coun-
seling, to donate supernumerary frozen testicular sperm for the
research. These patients had completed a pregnancy and had
more than one cryotube with stored sperm following the TESE
in our laboratory.Ovarian stimulationOvarian stimulation and oocyte retrieval were performed as
described in previous studies [9].ICSI procedureOn the day of oocyte retrieval, one of the cryotubes con-
taining cryopreserved spermatozoa was removed from the tank
of liquid nitrogen and placed in a 37 C water bath to thaw the
suspension. The thawed specimen was then prepared with the
Percoll-gradient method [10]. Nearly 90% of the spermatozoa
that were selected met the following criteria: (1) at least oc-
casional tail twitching; and (2) normal morphology, indicating
their relative viability. To prepare sperm droplets, 1 mL of
prepared sperm suspension was added to 2e4 mL of M2 me-
dium (Medicult, Copenhagen, Denmark) containing no poly-
vinylpyrrolidone, as described previously [11]. Subsequent to
the completion of the ICSI procedure, the oocytes were
cultured according to the standard IVF procedure [12]. The
embryos were classified according to the morphological
grading system described by Veeck in 1996 [13]. Luteal phase
supplementation of micronized progesterone (Utrogestan;
Piette International Laboratories, Brussles, Belgium), 800 mg
intravaginally daily, was begun on the day of oocyte retrieval
in all patients. Clinical pregnancy was determined by identi-
fying a gestational sac at a gestational age of 7 weeks by
means of transvaginal sonography.Assessment of outcome of pregnancy, infancy, and
childhoodGestational age, preterm labor, birth weight, neonatal res-
piratory distress syndrome, Apgar score, and intensive care
unit (ICU) admission rate were assessed independently. We
also evaluated both early (prior to 34 weeks gestation) and late
(34e37 weeks gestation) preterm labor. Major malformation
was defined as malformation causing death of functional
impairment, or requiring surgical treatment. The remaining
malformations were considered minor malformations. Mal-
formations were grouped into the following categories: oral
anomaly, congenital heart defects, musculoskeletal anomalies,
and urogenital anomalies.Statistical analysisThe conception outcomes following the ICSI procedures
were evaluated in terms of the number of fertilized oocytes
produced, the number of resultant cleaved oocytes, embryo
Fig. 2. Scattergram for the correlation analysis between the duration of
testicular sperm cryopreservation and the cleavage rate of zygotes following
intracytoplasmic sperm injection.
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rate of ongoing pregnancy. The outcomes following ICSI
using thawed sperm were compared with respect to the dura-
tion of storage of testicular spermatozoa. Statistical evaluation
was performed using one-way ANOVA, KruskaleWallis test,
ManneWhitney test, Fisher’s test, c2 tests, and linear
regression analysis where appropriate. Differences were
considered to be statistically significantly at p < 0.05.
This study was approved by our institutional board.
Results
The male partners of 188 couples provided testicular sperm
for cryopreservation in our center. For the total study sample,
the average number of cryotubes containing testicular sperm
for each couple was 6.5. There were about 300e500 sper-
matozoa in each cryotube. A total of 214 ICSI treatment cy-
cles were commenced for 132 couples during the study period.
Ninety-six pregnancies were obtained from a total of 204
transfers resulting in a pregnancy rate of 47.06% per transfer
and 45.28% per cycle. The cumulative pregnancy rate per
TESE was 74.1%. In addition, there were three incomplete
cycles, two cycles that did not result in fertilization, and one
cycle for which embryos were subsequently frozen due to the
accumulation of fluid in the uterine cavity. The average
number of patient cryotubes that remained stored in our cry-
obank following the ICSI cycles was 5.6 among those patients
who achieved pregnancy. The average number of patient
cryotubes that remained stored in our cryobank following the
ICSI cycles was 6.0 for the nonpregnant patients.
In order to evaluate the influence of the duration of cryo-
preservation on the potential for oocyte fertilization and sub-
sequent embryonic development, we performed a linear
regression analysis for the influence as shown in Figs. 1 and 2.
The correlation between the fertilization rate and the duration
of sperm-cryopreservation did not appear to be statistically
significant (R2 ¼ 0.0000007, p > 0.05; Fig. 1). The regression
line reveals that there was no significant correlation between
the cleavage rate of the zygotes and the duration of sperm
cryopreservation during the same cycle (R2 ¼ 0.0013,
p > 0.05; Fig. 2).Fig. 1. Scattergram for the correlation analysis between the duration of
testicular sperm cryopreservation and the fertilization rate following sperm
thawing and intracytoplasmic sperm injection.For assessment of the vitality of fresh or thawed testicular
spermatozoa, the eosin Y staining method and hypo-osmotic
swelling test were used for analysis. Mean percentage of
viable spermatozoa prior to freezing and after thawing and
washing are presented in Table 1. Post-thaw vitality was
significantly different from the vitality of fresh sperm in both
methods ( p < 0.001). The mean duration of cryopreservation
was 50 months. The mean percentage of vitality of sperma-
tozoa was not significantly different in three groups, which
varied in the duration of cryopreservation.
In order to examine the association of the results of various
treatments with the duration of cryopreservation of sperma-
tozoa, treatment cycles were divided into four groups
according to the duration of sperm cryopreservation (Table 2).
In this retrospective cohort study, there were 212 cycles of
ICSI, which were classified according to the duration of
cryopreservation (3 months, 3e12 months, 12e24 months,
and >24 months). As demonstrated by the results listed in
Table 2, the four groups were not significantly different in
terms of the mean number of oocytes fertilized and undergoing
cleavage, the mean number of good embryos transferred, and
the relative distribution of the morphology and grading of the
embryos transferred. The implantation rate, and the clinical
pregnancy rate per transfer also appeared to be similar for the
four groups. However, the live birth rate in the fourth group
(>24 months of cryopreservation) was significantly lower than
that of the other three groups. The abortion rate in the fourth
group was higher than that of the other three groups, but not
significantly ( p ¼ 0.058) possibly due to the sample size. We
also observed the greater mean maternal age (32.9  0.7
years) and body mass index (BMI; 23.1  2.9 kg/m2) in the
last group.
The influence of duration of sperm cryopreservation on the
neonatal outcome is shown in Table 3. There were 80 de-
liveries and 112 newborns in total in this assessment. Due to
the higher percentage of multiple pregnancies in the first
groups (3 months), the mean birth weight was significantly
lower than in other three groups. The mean maternal age at
delivery (35.2  1.3 years) was significantly greater in the
fourth group (>24 months) than in the other three groups. Due
Table 1
Effects of freezing and thawing on vitality of testicular spermatozoa.
Prefreeze Duration of cryostorage (mo)
Post-thaw <36 >36e48 >48
Store time (mo) 50.9  12.2 31  2.7 44.3  2.2 62.3  5.1
Eosin Y (%) 73.2  6.6 50.2  7.1* 44.6  6.3 55  3.3 50.5  7.4a
Hypo-osmotic (%) 71.3  4.7 50.8  8.6* 50.2  6.8 58.3  8.9 47.9  6.9b
Swelling
Data are presented as mean  standard error of the mean.
*Post-thaw results on vitality are significantly different ( p < 0.001) from pre-freeze results using ManneWhitney test.
a,bPost-thaw results on vitality are not significantly different respectively in three groups according to the duration of cryopreservation ( p ¼ 0.417 and p ¼ 0.310)
using one-way ANOVA.
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age for singleton infants were significantly lower than in the
other groups. Thus, the proportion of pregnancies complicated
by preterm labor (<37 weeks or <34 weeks) in singleton
pregnancies was significantly higher than in the other three
groups; however, neonatal respiratory distress syndrome,
Apgar scores, and rate of ICU admission after birth of the
newborn were not influenced by the maternal age at delivery.
Following examination of the newborn, the proportion infants
with minor or major congenital anomalies was not different
among the four groups.
Discussion
Although the mean percentage of viability of spermatozoa
in each cryotube decreased from 73.2% prior to freezing to
50.2% after thawing, the number of viable spermatozoaTable 2
Influence of duration of sperm-cryopreservation upon the outcome of embryos in
3 >3e12
No. of cycles commenced 92 55
No. of ICSI cycle 92 54
Female age (y) 31.0  0.5 31.5  0.6
Body mass index (kg/m2) 21.9  2.4 21.7  2.7
Total no. of injected oocytes 594 324
Mean no. of injected oocytes 6.4  0.3 5.8  0.4
Total no. of fertilized oocytes 544 277
Mean rate of fertilized oocytes 91.4  1.5 83.2  3.2
Total no. of cleaved oocytes 522 269
Mean rate of cleaved oocytes 96.2  1.5 96.6  1.8
No. of blastomeres in day 2 embryos
3 121 (23.18) 71 (26.39)
 4 401 (76.82) 199 (73.61)
Embryo quality
Gooda 418 (80.08) 213 (79.18)
Poorb 104 (19.92) 50 (20.82)
Estradiol level 1840.5  142.6 1935.7  1
Mean no. of transferred good embryos 2.1  0.1 2.1  0.2
Clinical PR per transfer cycle 45/89 (50.56) 23/51 (45.1
Implantation rate 74/274 (26.28) 29/157 (18.
Live birth rate 38/89 (42.69) 21/51 (41.1
Abortion rate 5/89 (5.62) 2/51 (3.92)
Data are presented as mean  standard error of the mean or n (%).
PR ¼ pregnancy rate.
* The result are significantly different (p < 0.05) compared with the result in the
a Good embryos: Grade 1e2 embryos; b Poor embryos: Grade 3e5 embryos.(at least 100) was enough to perform ICSI in each cycle in this
study. Fertilization potential did not appear to be affected by
the duration of cryostorage in liquid nitrogen up to at least 2
years. The subsequent development of embryos in vitro also
did not appear to be significantly affected by the duration of
the cryopreservation process. The clinical outcomes including
the pregnancy rate and implantation rate were not influenced
by the duration of cryopreservation of testicular sperm; how-
ever, the live-birth rate was significantly lower in the last
group with longer store time (>24 months), due to more
advanced maternal age. The influence of maternal age at de-
livery was also shown in the neonatal outcomes in the study.
Excluding the maternal age factor, the neonatal outcomes,
including the neonatal respiratory distress syndrome, Apgar
score, and ICU admission after birth of the newborn were not
affected by the duration of cryostorage. The proportion of
minor or major congenital anomalies was also not affected byvitro.
Duration of cryostorage (mo)
>12e24 >24 Total
26 41 214
26 40 212
32.1  0.9 32.9  0.7* 31.7  3.8
22.1  2.7 23.1  2.9* 22.1  2.7
168 256 1342
6.4  0.9 6.2  0.5 6.3  3.0
150 230 1201
80.7  6.2 90.0  1.9 87.7  14.0
149 228 1168
94.5  3.9 93.4  3.7 95.6  7.7
34 (22.82) 40 (17.54)* 266 (22.75)
115 (77.18) 188 (82.46)* 903 (77.25)
110 (73.82) 172 (75.44) 913 (78.57)
39 (26.17) 56 (24.56) 249 (21.43)
78.1 1914.2  290.0 1766.8  202.0 1858.0  1008.4
2.0  0.2 2.1  0.1 2.1  0.9
0) 12/25 (48.00) 16/39 (41.03) 96/204 (47.06)
47) 18/83 (21.68) 17/95 (17.89) 137/609 (22.5)
7) 11/25 (44) 10/39 (25.64)* 80/204 (39.2)
1/25 (4.00) 6/39 (15.38) 14//204 (6.86)
other two groups.
Table 3
Influence of duration of sperm cryopreservation on the neonatal outcome.
Duration of cryostorage (mo)
3 >3e12 >12e24 >24 Total
Female age (y) at delivery 30.5  0.7 32.2  1.1 31.8  1.4 35.2  1.3* 31.7  4.0
No. of delivery 38 21 11 10 80
No. of live birth 59 27 14 12 112
Multiple pregnancy
Twins 15 (39.47) 4 (19.04) 3 (27.27) 2 (20) 24 (30)
High-order 3 (7.89) 1 (4.7) 4 (5)
Gestational age (wk) 36.8  1.9 37.6  1.7 37.5  2.1 36.5  2.2 36.9  2.1
Gestational age (wk) of singleton 38.8  1.0 38.1  1.3 38.5  1.5 36.7  2.3*
Birth weight (g) 2555.9  88.0* 2865.0  117.1 2779.2  245.7 2785.8  197.9 2664.9  527.8
Birth weight (g) of singleton 3157.5  306.2 3112.8  257.5 3303.7  462.1 2842.5  697.5* 3117.81  69.8
Neonatal respiratory distress syndrome 11 (18.6) 3 (11.1) 3 (21.4) 2 (16.6) 19 (16.9)
Neonatal respiratory distress syndrome of singleton 2 (10) 1 (6.2) 0 (0) 1 (12.5) 4 (7.6)
Apgar score: 1 min < 5 or 5 min < 7 3 (5.0) 4 (14.8) 2 (14.2) 0 (0) 9 (8.0)
Apgar score: 1 min < 5 or 5 min < 7 of singleton 0 (0) 1 (6.2) 0 (0) 0 (0) 1 (1.9)
Prematurity
<37 weeks, late preterm 22 (39.28) 9 (34.61) 3 (21.43) 6 (50) 44 (39.28)
<37 weeks, late preterm of singleton 0 0 0 4 (50)* 4 (7.6)
<34 weeks, early preterm 10 (17.85) 3 (11.53) 1 (7) 2 (16.6) 19 (16.96)
<34 weeks, early preterm of singleton 0 0 0 2 (25)* 2 (3.8)
ICU admission after birth 8 (13.5) 4 (14.8) 2 (14.2) 1 (8.3) 15 (13.3)
ICU admission after birth of singleton 2 (10) 2 (12.5) 0 (0) 1 (12.5) 5 (9.6)
Minor congenital anomalies 6 (10.16) 4 (14.81) 1 (7.14) 2 (12.67) 13 (11.6)
Major congenital anomalies (TOF) 1 (1.69) 0 (0.00) 0 (0.00) 0 (0.00) 1 (0.89)
Data are presented as mean  standard error of the mean or n (%).
ICU ¼ intensive care unit; TOF ¼ tetralogy of Fallot.
* The result are significantly different (p  0.05) compared with the result in the other two groups.
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outcomes, we observed a strong tendency towards lower
gestational age and birth weight among the singletons, and a
higher percentage of early and later preterm labor among the
singletons in the last group. The major factor appears to be the
maternal age at delivery (35.2 years) in the last group,
compared with the other three groups (30.5e32.2 years).
There were no significant differences in pregnancy outcome
among the other three groups.
As discussed by Baird et al [14], the endometrium is not a
limiting factor for older woman who desired conception; the
endometrium was able to support implantation and early
pregnancy in older woman. Advanced age of ovaries has an
impact on the quality of the oocyte, and reflects the higher
incidence of spontaneous abortion. This conclusion corrobo-
rates our observation that advanced maternal age seems to
have a negative influence on the rate of live birth.
The impact of greater BMI on the outcome of assisted
reproduction is an ongoing issue. One study focusing on the
relationship between BMI and the endometrium revealed a
similar rate of miscarriage in groups with different BMI [15];
however; a negative trend was also observed as BMI increased,
and the authors stated that the extraovarian effects of increased
BMI should be taken into account. Our results suggest that
higher maternal BMI could result in an alteration of the uterine
environment, but not in the quality of the embryos. One paper
with systemic review suggests that obesity (BMI > 25 kg/m2)
has a negative impact, resulting in a highermiscarriage rate [16].
Bellver et al [17] observed that maternal obesity could impairthe IVF outcome, but not the embryo quality. This is, again,
compared with our finding that the quality of transferred em-
bryos in the last group seems similar to that of other groups, but
the implantation rate still showed a negative trend.
It has been shown the birth outcomes of children conceived
with nonejaculated sperm are comparable to those of children
conceived with ejaculated sperm [18,19]. Furthermore, no
increase in the rate of anomalies is reported in children
conceived through ICSI with epididymal or testicular sperm
when compared with children conceived with ejaculated
sperm [19e21]. To date, the pregnancy outcome and neonatal
health of children born after ICSI using thawed testicular
sperm from different duration of cryopreservation is not well
documented except in the present study. Concerns have been
raised concerning the health of the children born after ICSI
with cryopreservation of testicular spermatozoa [22]. Major
malformations were found in 31 out of 670 (4.6%) in the
group of ICSI with testicular sperm [23]. In our study, the
major malformation rate was 0.89 % in the group of ICSI with
thawed testicular sperm. Tetralogy of Fallot occurs once in
approximately 400 million live births [24]. In the previous
study [25], the cryopreserved testicular spermatozoa and
ejaculated spermatozoa in cases of severe oligoasthenoter-
atospermia had a similar obstetric and perinatal outcome.
In conclusion, a standardized ICSI procedure using fro-
zenethawed testicular tissue elucidates ICSI outcomes, preg-
nancy outcome, and neonatal outcome that appear not to be
affected by the duration of the period of cryostorage; however,
the maternal age and BMI at conception are critical factors that
334 Y.-R. Tsai et al. / Taiwanese Journal of Obstetrics & Gynecology 52 (2013) 329e334will influence the clinical outcomes. We suggest that an earlier
start of the ICSI cycle following the cryopreservation of
testicular spermatozoa of infertile couples is preferable because
longer preservation is associated with more advanced maternal
age. Maintenance of an appropriate body weight is also rec-
ommended for women achieving pregnancy through this
procedure.
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